Delivery Order SPE2DB20D1109-SPE2DB25FP58A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,732.92, for the supply of Pediarix 0.5 ML syringes effective September 11, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $3,261.55 for Pediarix 0.5 ML syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Pediarix 0.5 ML syringes valued at $7,613.09. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,331.52 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric vaccination product sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation and is executed under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,759.00 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ml syringes. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, and this order represents one of numerous pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,442.56 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Pediarix 0.5 mL syringes. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,711.44 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child order under a larger vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives...
- The Defense Logistics Agency awarded a delivery order valued at $12,360.60 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, a pediatric vaccine combination product. This firm fixed price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $10,577.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Pediarix 0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will take place at AmerisourceBergen's corporate...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP58ADelivery Order
The Defense Logistics Agency awarded a $8,506 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be performed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a key distribution hub for federal medical procurement. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contracts covering vaccines, medications, and medical supplies across multiple therapeutic domains. The company's ability to win competitive awards demonstrates its capability to meet federal procurement requirements, and it continues to serve as a critical vendor for Defense Health Agency and other government healthcare systems through this flexible contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/15/25 |